Robotic pill tech found to be safe, tolerable in early human study, paving ground for oral biologics
Transforming injectables into pills is hardly a novel idea, but a string of pharmaceutical/chemical efforts to evade the enzymes that break down the oral drug before it can be absorbed have largely hit a wall. Earlier this month, an animal study captured the spotlight for the potential of its blueberry sized robotic pill designed to deliver an insulin shot inside the stomach — but California-based Rani Therapeutics on Thursday said it has successfully tested its robotic pill for safety and tolerability in humans, paving the way for efficacy studies that could open the door to a colossal market to enhance treatment compliance, diminish the need for physician-led therapeutic administration and placate needle-phobic patients.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.